These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 34655181)
1. Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol. Krumpl G; Ulč I; Trebs M; Kadlecová P; Hodisch J; Husch B Clin Pharmacol Drug Dev; 2022 Mar; 11(3):309-317. PubMed ID: 34655181 [TBL] [Abstract][Full Text] [Related]
2. Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group. Krumpl G; Ulc I; Trebs M; Kadlecová P; Hodisch J Eur J Clin Pharmacol; 2017 Apr; 73(4):417-428. PubMed ID: 28091703 [TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults. Krumpl G; Ulč I; Trebs M; Kadlecová P; Hodisch J BMC Pharmacol Toxicol; 2020 Nov; 21(1):82. PubMed ID: 33239108 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Pharmacodynamics of Low-, Intermediate-, and High-Dose Landiolol and Esmolol During Long-Term Infusion in Healthy Whites. Krumpl G; Ulč I; Trebs M; Kadlecová P; Hodisch J; Maurer G; Husch B J Cardiovasc Pharmacol; 2018 Mar; 71(3):137-146. PubMed ID: 29112591 [TBL] [Abstract][Full Text] [Related]
5. The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia. Oda Y; Nishikawa K; Hase I; Asada A Anesth Analg; 2005 Mar; 100(3):733-737. PubMed ID: 15728061 [TBL] [Abstract][Full Text] [Related]
6. Dobutamine Alters the Pharmacokinetic and Pharmacodynamic Behavior of Esmolol. Krumpl G; Ulč I; Trebs M; Hodisch J; Kadlecová P; Husch B Cureus; 2020 Dec; 12(12):e12217. PubMed ID: 33500851 [TBL] [Abstract][Full Text] [Related]
7. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Sasao J; Tarver SD; Kindscher JD; Taneyama C; Benson KT; Goto H Can J Anaesth; 2001 Nov; 48(10):985-9. PubMed ID: 11698317 [TBL] [Abstract][Full Text] [Related]
8. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system]. Mio Y Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544 [TBL] [Abstract][Full Text] [Related]
9. Landiolol and esmolol prevent tachycardia without altering cerebral blood flow. Saito S; Nishihara F; Akihiro T; Nishikawa K; Obata H; Goto F; Yuki N Can J Anaesth; 2005 Dec; 52(10):1027-34. PubMed ID: 16326671 [TBL] [Abstract][Full Text] [Related]
10. Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts. Kurosawa S; Kanaya N; Niiyama Y; Nakayama M; Fujita S; Namiki A Can J Anaesth; 2003 May; 50(5):489-94. PubMed ID: 12734159 [TBL] [Abstract][Full Text] [Related]
11. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. Ikeshita K; Nishikawa K; Toriyama S; Yamashita T; Tani Y; Yamada T; Asada A J Anesth; 2008; 22(4):361-6. PubMed ID: 19011773 [TBL] [Abstract][Full Text] [Related]
12. Symptomatic and hemodynamic recovery following dobutamine stress echo: benefit of low-dose esmolol administration. Abdullah EE; Pollick C Int J Card Imaging; 1997 Feb; 13(1):53-7. PubMed ID: 9080239 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions. Nasrollahi-Shirazi S; Sucic S; Yang Q; Freissmuth M; Nanoff C J Pharmacol Exp Ther; 2016 Oct; 359(1):73-81. PubMed ID: 27451411 [TBL] [Abstract][Full Text] [Related]
14. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study. Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of near infrared spectroscopy for detecting the β blocker-induced decrease in cerebral oxygenation during hemodilution in a swine model. Kurita T; Morita K; Sato S J Clin Monit Comput; 2015 Dec; 29(6):779-88. PubMed ID: 25876017 [TBL] [Abstract][Full Text] [Related]
16. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study. Hoshi T; Sato A; Nishina H; Kakefuda Y; Wang Z; Noguchi Y; Aonuma K J Cardiol; 2012 Oct; 60(4):252-6. PubMed ID: 22835733 [TBL] [Abstract][Full Text] [Related]
17. Comparative effects of ultra-short-acting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons. Tanahashi S; Iida H; Dohi S; Oda A; Osawa Y; Yamaguchi S Eur J Anaesthesiol; 2009 Mar; 26(3):196-200. PubMed ID: 19237982 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic and -kinetic Behavior of Low-, Intermediate-, and High-Dose Landiolol During Long-Term Infusion in Whites. Krumpl G; Ulč I; Trebs M; Kadlecová P; Hodisch J; Maurer G; Husch B J Cardiovasc Pharmacol; 2017 Jul; 70(1):42-51. PubMed ID: 28437278 [TBL] [Abstract][Full Text] [Related]
19. Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts. Shibata S; Okamoto Y; Endo S; Ono K J Pharmacol Sci; 2012; 118(2):255-65. PubMed ID: 22293301 [TBL] [Abstract][Full Text] [Related]
20. Effects of landiolol, a short-acting beta-1 blocker, on hemodynamic variables during emergence from anesthesia and tracheal extubation in elderly patients with and without hypertension. Miyazaki M; Kadoi Y; Saito S J Anesth; 2009; 23(4):483-8. PubMed ID: 19921354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]